Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 985.71% vs 0.00% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -5.43% vs -52.69% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 6.47% vs -49.90% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Syndax Pharmaceuticals, Inc. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 90.00% vs 159.74% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 985.71% vs 0.00% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 15.33% vs 9.98% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -5.43% vs -52.69% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 16.89% vs 13.38% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 6.47% vs -49.90% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -2.47% vs 68.75% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






